(Q37305883)

English

Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial

scientific article published on 21 October 2008

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial (English)

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

prostatic hypertrophy

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Alan R. Kristal

object named as

Alan R Kristal

1

0 references

Marian L Neuhouser

5

object named as

Marian L Neuhouser

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Jeannette M. Schenk

2

object named as

Jeannette M Schenk

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Frank Z. Stanczyk

8

object named as

Frank Z Stanczyk

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

author name string

YoonJu Song

3

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Kathryn B Arnold

4

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Phyllis J Goodman

6

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Daniel W Lin

7

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Ian M Thompson

9

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

language of work or name

0 references

publication date

21 October 2008

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

American Journal of Epidemiology

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

168

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

12

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

1416-1424

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Insulin-like growth factor-I, insulin-like growth factor binding protein-3 and risk of benign prostate hyperplasia in the prostate cancer prevention trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

6 September 2017

Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

6 September 2017

The decline of androgen levels in elderly men and its clinical and therapeutic implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

6 September 2017

Serum sex hormones and measures of benign prostatic hyperplasia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

6 September 2017

Nutritional genomics: the next frontier in the postgenomic era

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

6 September 2017

The influence of finasteride on the development of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

6 September 2017

Study design of the Medical Therapy of Prostatic Symptoms (MTOPS) trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

6 September 2017

Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

6 September 2017

The natural history of benign prostatic hyperplasia: what have we learned in the last decade?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

6 September 2017

Pathology of benign prostatic hyperplasia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

6 September 2017

Biochemical and pharmacogenetic dissection of human steroid 5 alpha-reductase type II

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

6 September 2017

Serum steroids in relation to benign prostatic hyperplasia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

6 September 2017

Endocrine environment of benign prostatic hyperplasia: prostate size and volume are correlated with serum estrogen concentration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

6 September 2017

Comparative study of plasma steroid and steroid glucuronide levels in normal men and in men with benign prostatic hyperplasia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

6 September 2017

The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

6 September 2017

Hormone blood levels and their inter-relationships in normal men and men with benign prostatic hyperplasia (BPH)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

6 September 2017

Serum steroids in normal males and patients with prostatic diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

6 September 2017

Serum Hormone Levels in Benign Prostatic Hyperplasia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

6 September 2017

Androgens in Patients with Benign Prostatic Hyperplasia Before and After Prostatectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

6 September 2017

Plasma steroid and protein hormone concentrations in patients with benign prostatic hypertrophy and in normal men

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

14 September 2017

Relationship between serum testosterone and measures of benign prostatic hyperplasia in aging men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

14 September 2017

Potential action of IGF-1 and EGF on androgen receptor nuclear transfer and transactivation in normal and cancer human prostate cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

14 September 2017

Effects of dietary fat and fiber on plasma and urine androgens and estrogens in men: a controlled feeding study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

26 June 2018

A prospective study of plasma hormone levels, nonhormonal factors, and development of benign prostatic hyperplasia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

26 June 2018

Effect of Finasteride, a 5α-Reductase Inhibitor on Prostate Tissue Androgens and Prostate-Specific Antigen*

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

26 June 2018

Altered blood androgens in elderly men with prostate hyperplasia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

26 June 2018

Effect of alcohol (ethanol) administration on sex-hormone metabolism in normal men

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

26 June 2018

Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

2 September 2018

Associations between polymorphisms in the steroid 5-alpha reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

2 September 2018

Novel male hormonal contraceptive combinations: the hormonal and spermatogenic effects of testosterone and levonorgestrel combined with a 5alpha-reductase inhibitor or gonadotropin-releasing hormone antagonist

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

2 September 2018

Polymorphisms in the 5alpha reductase type 2 gene and urologic measures of BPH.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

2 September 2018

Serum concentrations of sex hormones in men with severe lower urinary tract symptoms and benign prostatic hyperplasia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

2 September 2018

A case-based evaluation of SRD5A1, SRD5A2, AR, and ADRA1A as candidate genes for severity of BPH.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

2 September 2018

The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

2 September 2018

Interrelationships between plasma testosterone, SHBG, IGF-I, insulin and leptin in prostate cancer cases and controls

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

2 September 2018

Association of V89L SRD5A2 polymorphism with prostate cancer development in a Japanese population

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

2 September 2018

Relationship of serum sex-steroid hormones and prostate volume in African American men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

2 September 2018

Insulin-like growth factors and risk of benign prostatic hyperplasia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

2 September 2018

Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

2 September 2018

Analysis of relations between serum levels of epitestosterone, estradiol, testosterone, IGF-1 and prostatic specific antigen in men with benign prostatic hyperplasia and carcinoma of the prostate.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

2 September 2018

Androgen induction of steroid 5 alpha-reductase may be mediated via insulin-like growth factor-I.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

2 September 2018

Statistical methods in cancer research. Volume I - The analysis of case-control studies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

2 September 2018

Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

2 September 2018

Peripheral hormone levels in controls and patients with prostatic cancer or benign prostatic hyperplasia: results from the Dutch-Japanese case-control study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727187

20 October 2018

Plasma estradiol, free testosterone, sex hormone binding globulin binding capacity, and prolactin in benign prostatic hyperplasia and prostatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18945688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Longitudinal evaluation of serum androgen levels in men with and without prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18945688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men

1 reference

https://pubmed.ncbi.nlm.nih.gov/18945688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of finasteride, a 5 alpha-reductase inhibitor, on circulating androgens and gonadotropin secretion in hirsute women

1 reference

https://pubmed.ncbi.nlm.nih.gov/18945688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endocrine status in elderly men with lower urinary tract symptoms: correlation of age, hormonal status, and lower urinary tract function. The Prostate Study Group of the Austrian Society of Urology

1 reference

https://pubmed.ncbi.nlm.nih.gov/18945688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of and racial/ethnic variation in lower urinary tract symptoms and noncancer prostate surgery in U.S. men

1 reference

https://pubmed.ncbi.nlm.nih.gov/18945688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treating prostate cancer: a rationale for targeting local oestrogens

1 reference

https://pubmed.ncbi.nlm.nih.gov/18945688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Obesity and benign prostatic hyperplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18945688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma steroid hormones, surgery for benign prostatic hyperplasia, and severe lower urinary tract symptoms

1 reference

https://pubmed.ncbi.nlm.nih.gov/18945688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Testicular and adrenocortical function in healthy men and in men with benign prostatic hyperplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18945688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma steroids in benign prostatic hypertrophy and carcinoma of the prostate

1 reference

https://pubmed.ncbi.nlm.nih.gov/18945688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An investigation of the relationship between sex-steroid levels and urological symptoms: results from the Boston Area Community Health survey

1 reference

https://pubmed.ncbi.nlm.nih.gov/18945688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum hormone levels among patients with prostatic carcinoma or benign prostatic hyperplasia and clinic controls

1 reference

https://pubmed.ncbi.nlm.nih.gov/18945688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum sex steroid hormones and lower urinary tract symptoms in Third National Health and Nutrition Examination Survey (NHANES III)

1 reference

https://pubmed.ncbi.nlm.nih.gov/18945688

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/AJE/KWN272

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37305883&oldid=2174162015"